Early research (Phase 1)Study completedNCT05305300
What this trial is testing
A Phase I Study to Evaluate Safety, Tolerability, and Immunogenicity of a PIKA COVID-19 Vaccine in Healthy Individuals
Who this might be right for
COVID-19 Pandemic
Yisheng Biopharma (Singapore) Pte. Ltd. 135